Trailing-twelve-month (TTM) revenue is $15.54 Million with a year-over-year growth of +153.23%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $4,175,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-26 |
| Q4 FY2025Period ended 2025-12-31 | $3,534,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-24 |
| Q1 FY2026Period ended 2026-03-31 | $3,646,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-09 |
| Q2 FY2026Period ended 2026-06-30 | $4,186,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $15,541,000 |
Current P/S: $369,935 market capitalization ÷ $15,541,000 TTM revenue = 0.02x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $4.19M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:07:17.874Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2020-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2020-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20152015-12-31 · USD | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Direct To Retail License | $154M | $144M | $121M | $72M | $43M | $31M |
| Other Licenses | $54M | $56M | $237,000 |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20152015-12-31 · USD | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| J P | $35M | N/A | N/A | N/A | N/A | N/A |
| JAPAN | N/A | $45M | N/A |
$15.54M
$15.54 Million
+153.23%
vs. $6.14M a year ago (TTM)
+15.84%
3 Year compound annual growth rate
1 Year
+153.23%
3 Year
+15.84%
5 Year
N/A
10 Year
(27.28%)
15 Year
(19.00%)
20 Year
(5.97%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $11.26M | +$5.95M | +112.02% |
| 2024 | $5.31M | +$833,000 | +18.61% |
| 2023 | $4.48M | ($2.77M) | (38.19%) |
| 2022 | $7.24M | +$1.28M | +21.47% |
| 2021 | $5.96M | ($143.02M) | (96.00%) |
| 2019 |
TTM Growth
+153.23%
3-Year CAGR
+15.84%
5-Year CAGR
N/A
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:07:17.874Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| Wholesale License | $171M | $168M | $105M | $113M | $105M | $76M |
|---|
| N/A |
| N/A |
| N/A |
| Other Countries | $94M | $94M | $62M | $67M | $61M | $44M |
|---|
| U S | $250M | N/A | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | N/A | $230M | $164M | $120M | $88M | $65M |
|---|
| $148.98M |
| ($38.70M) |
| (20.62%) |
| 2018 | $187.69M | ($38.14M) | (16.89%) |
| 2017 | $225.83M | ($142.63M) | (38.71%) |
| 2016 | $368.46M | ($10.74M) | (2.83%) |
| 2015 | $379.20M | ($82.05M) | (17.79%) |
